International Journal of Cardiovascular ResearchISSN: 2324-8602

All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.

Research Article, Int J Cardiovas Res Vol: 6 Issue: 2

Angiotensin II as an Indicator of Left ventricular Hypertrophy in Uncontrolled Treated Hypertensive Patients

Tamer M Abu Arab*, Moustafa El Nozahi, Wessam Wahid and Hany F Hanna
Department of cardiology, Faculty of medicine, Ain Shams University, Cairo, Egypt
Corresponding author : Dr. Tamer M Abu Arab
Department of Cardiology, Faculty of medicine, Ain Shams University, Lotfy El-sayed st., Abbasia square, Cairo, Egypt, Postal code- 11566, Egypt
Tel: +201006004924
Fax: 0020224820416
E-mail: [email protected]
Received: December 19, 2016 Accepted: February 15, 2017 Published: February 20, 2017
Citation: Abu Arab TM, El Nozahi M, Wahid W, Hanna HF (2017) Angiotensin II as an Indicator of Left ventricular Hypertrophy in Uncontrolled Treated Hypertensive Patients. Int J Cardiovasc sRes 6:2. doi: 10.4172/2324-8602.1000305


Background: left ventricular hypertrophy (LVH) in uncontrolled hypertension is a major risk factor and the mechanism is not fully understood weather it is due to increased afterload or due to an angiotensin II (Ag II) mediated action on the heart. Objectives: we studied the relationship between Ag II serum level and concentric LVH in patients with hypertension. Methods: a total of 91 patients were included, all had long standing (≥ 5 years) essential uncontrolled treated hypertension and were categorized into two groups according to presence of concentric LVH by echocardiographic criteria (LV mass index (LVMI)>115 g/ m2 for men, LVMI>95 g/m2 for women and relative wall thickness (RWT)>0.42). Group I had 47 patients with LVH and group II had 44 patients without LVH. Ag II serum level was measured in all of them. Results: Ag II serum level was higher than normal range in all patients in both groups (cutoff value was taken as 30pg/ml). It was significantly higher in patients with LVH (group I) with mean level 70 pg/ml compared to 43 pg/ml in patients without LVH (group II) (p=0.000). In patients with LVH, Ag II serum level had positive correlation with BMI (r=0.325, P=0.026) but it had no correlation to age, gender, diabetes, duration of hypertension and, surprisingly no correlation to severity of LVH. Conclusion: Patients with LVH have higher serum level of Ag II compared to patients without LVH but it cannot be considered as the only causative factor for LVH in hypertensive patients and other factors should be considered.

Keywords: Angiotensin II; Hypertension; Left ventricular hypertrophy

international publisher, scitechnol, subscription journals, subscription, international, publisher, science

Track Your Manuscript

Recommended Conferences

Media Partners

open access